AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: 2015 AGM Chairmans and CEO Presentations, page-14

  1. 5,796 Posts.
    lightbulb Created with Sketch. 736
    Just a quick note from me.

    A solid AGM - no fanfare, just reality and direction.
    Business > research
    Refinement > expansion (find out what really is viable)
    Cost effectivneness/value creation/ accountability
    All come to mind.
    Peter Lankau 10/10 very impressive, well credentialed, great resource for the company
    Ross Murdoch 9/10 (sorry Ross - just wanted some scope for you to improve ) - a doer/business driven/value driven/ realistic
    Greg Collier (didn't hear enough about)

    I'll leave the detail to my collegue who was sitting next to me - far more succinct and informative.
    A point to consider there has been a long black out period so no director buying opportunity, but it was intimated that directors will.

    Finally Playez will have to find another high horse to climb.

    No rose coloured glasses from this board just a desire to create shareholder value.
    Over to you hottod.
    And jamwolf, I'll assume your comment was tongue in cheek, as your statement was as opposite from the truth as you can get. The message was how not to fritter away money anymore.
    Last edited by goldenchook: 18/05/15
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $2.634K 1.064M

Buyers (Bids)

No. Vol. Price($)
56 92244418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60312650 22
View Market Depth
Last trade - 13.20pm 26/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.